Mithra Pharmaceuticals SA (MITRA.BR) Stock Price, Quote, News and Overview

What is the stock price of Mithra Pharmaceuticals SA today?

The current stock price of MITRA.BR is 0.216 EUR. The price decreased by -1.82% in the last trading session.

What is the ticker symbol for Mithra Pharmaceuticals SA stock?

The exchange symbol of Mithra Pharmaceuticals SA is MITRA and it is listed on the Euronext Brussels exchange.

On which exchange is MITRA.BR stock listed?

MITRA.BR stock is listed on the Euronext Brussels exchange.

What is the price forecast or stock price prediction for Mithra Pharmaceuticals SA stock?

9 analysts have analysed MITRA.BR and the average price target is 3.8 EUR. This implies a price increase of 1659.03% is expected in the next year compared to the current price of 0.216. Check the Mithra Pharmaceuticals SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is Mithra Pharmaceuticals SA worth?

Mithra Pharmaceuticals SA (MITRA.BR) has a market capitalization of 14.93M EUR. This makes MITRA.BR a Nano Cap stock.

How many employees does Mithra Pharmaceuticals SA have?

Mithra Pharmaceuticals SA (MITRA.BR) currently has 229 employees.

What are the support and resistance levels for Mithra Pharmaceuticals SA (MITRA.BR) stock?

Mithra Pharmaceuticals SA (MITRA.BR) has a resistance level at 0.24. Check the full technical report for a detailed analysis of MITRA.BR support and resistance levels.

Is Mithra Pharmaceuticals SA (MITRA.BR) expected to grow?

The Revenue of Mithra Pharmaceuticals SA (MITRA.BR) is expected to grow by 175.31% in the next year. Check the estimates tab for more information on the MITRA.BR EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy Mithra Pharmaceuticals SA (MITRA.BR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of MITRA.BR, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of MITRA.BR, evaluating the profitability, health, valuation and growth aspects
• Mithra Pharmaceuticals SA (MITRA.BR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• Mithra Pharmaceuticals SA (MITRA.BR) Sales and EPS estimates to see what analysts future expectations are.
• Mithra Pharmaceuticals SA (MITRA.BR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• Mithra Pharmaceuticals SA (MITRA.BR) Insider and Institutional Ownership to learn about the owners and their transactions.
• Mithra Pharmaceuticals SA (MITRA.BR) Stock Chart to make your own analysis
• Mithra Pharmaceuticals SA (MITRA.BR) Latest news and press-releases to stay up to date.

Does Mithra Pharmaceuticals SA (MITRA.BR) stock pay dividends?

MITRA.BR does not pay a dividend.

When does Mithra Pharmaceuticals SA (MITRA.BR) report earnings?

Mithra Pharmaceuticals SA (MITRA.BR) will report earnings on 2024-09-26.

What is the Price/Earnings (PE) ratio of Mithra Pharmaceuticals SA (MITRA.BR)?

Mithra Pharmaceuticals SA (MITRA.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.42).

ChartMill assigns a fundamental rating of 2 / 10 to MITRA.BR. Both the profitability and financial health of MITRA.BR have multiple concerns.

Over the last trailing twelve months MITRA.BR reported a non-GAAP Earnings per Share(EPS) of -1.42. The EPS increased by 32.7% compared to the year before.

ChartMill assigns a Buy % Consensus number of 36% to MITRA.BR. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 32.9% and a revenue growth 175.31% for MITRA.BR